Trump’s Whiplash Tariffs and HHS Layoffs Set Biopharma Business Ablaze
All through the previous a number of weeks, the actions taken by the Trump administration to downsize the Division of Well being and Human Companies and levy tariffs throughout industries whereas threatening pharma-specific import taxes have activated an unprecedented stage of discourse on social media and past. Right here, we spotlight among the strongest quotes.
___________________________________________________________________
“This week’s gorgeous reversals reveal how shortly issues can change on each the coverage/macro entrance and for equities.” —Jefferies International Analysis & Technique
“Biotech is in a doom loop.” —Adam Feuerstein, biotech reporter, STAT Information, on X
___________________________________________________________________
“The FDA as we’ve identified it’s completed.” —Former FDA Commissioner Robert Califf, on LinkedIn
“I’d count on this can be a slow-moving disaster, not a right away disaster.” —Former FDA Commissioner Janet Woodcock, per Fierce Biotech
“His [Marks’] resignation is excess of the departure of a extremely revered determine. It’s a stark and unequivocal warning.” —Jeremy Levin, CEO, Ovid Therapeutics, on LinkedIn
“Twenty-five years in the past, it was frequent to listen to complaints a couple of ‘drug lag’—the notion that Europeans routinely loved medical advances years earlier than their American counterparts. . . . Right this moment, the cumulative barrage on that drug-discovery enterprise, threatens to swiftly deliver again these irritating delays for American customers, significantly affecting uncommon ailments and areas of serious unmet medical want.” —Scott Gottlieb, former FDA Commissioner, on X
“The present uncertainty surrounding the FDA’s capability to operate creates downstream uncertainty from traders who will query whether or not the FDA can do its job as it’s being reinvented.” —No Affected person Left Behind letter to Sen. Invoice Cassidy
“Within the earlier than occasions (earlier than the enactment of person charges at FDA) the typical new drug utility overview time was two and a half years. Right this moment the typical overview time is 10 months. The most important winners are sufferers ready for brand new remedies and cures. Reversing this development is unhealthy information for everybody.” — David Beier, managing director at Bay Metropolis Capital, on LinkedIn.
“[I]n the parlance of the military- this can be a classical ‘decapitation strike’. . . . It weakens one of many core establishments defending Individuals.” —Jeremy Levin, CEO, Ovid Therapeutics, on LinkedIn
___________________________________________________________________
“Tariffs will improve costs for generic treatment considerably on the expense of American customers and they’ll hit probably the most weak US residents the toughest.” —ING, per PharmaPhorum
“International provide chains are complicated, with pharma among the many most—it’s not so simple as transferring the place somebody screws in little screws to make an iPhone.” —BMO Capital Markets
“Whereas large pharma may sidestep many of the injury, early-stage biotech startups are feeling the warmth, with rising R&D prices, disrupted provide chains, and longer timelines. This isn’t simply commerce coverage. It instantly impacts innovation velocity, capital effectivity, and medical momentum.” —Tapas Saha, senior director, Medical Growth & Medical Communications, Anavex Life Sciences, on LinkedIn
“It’s laborious to consider that any administration would wish to hurt U.S. firms, not to mention U.S. biopharma, which is, in our view, an especially enviable sector.” —BMO Capital Markets
___________________________________________________________________
“Pricey Science, I write to you as we speak after studying the information that HHS Secretary Kennedy has introduced plans to ‘decide the reason for autism by September.’ My pen is heavy with disbelief, my thoughts reeling on the implication that each one this time, you’ve merely been too lazy or incompetent to search out the reply that apparently may be found in only a few months.” —Unbiased Science through Jessica Steier, govt director, Science Literacy Lab, on LinkedIn
“As a result of frankly we don’t belief these m——f——. They’d write over it or erase the entire database.” —Peter Marks, former Middle for Biologics Analysis and Analysis director, on not offering Kennedy’s crew enhancing entry to drug security studies, to AP Information
